. 2018 Jun 27;18(12):1700465. doi: 10.1002/pmic.201700465

Table 3.

Proteins with the highest tumor‐enriched cohort coverage (aTaCC ≥ 7%)

Uniprot acc.	Protein description	Protein length [aa]	Peptides/patient	aTaCC [%]	Peptides identified
P23528	Cofilin‐1 (CFL‐1)	166	3.6	16.3	IILEEGKEILV \| ILEEGKEILV \| SAVISLEGKPL \| DGVIKVFNDMKVRKSSTPE \| GVIKVFNDMKVRKSSTPE \| MIYASSKDAIK \| VIKVFNDMKVRKSSTPE \| A ^aSGVAVSD \| GSAVISLEGKPL
P24001	Interleukin‐32 (IL‐32)	234	4.0	11.4	KVMRWFQAM \| KVVALVHAV \| DMKKLKARM ^o \| GVLAWVKEK \| SQHQAIERF \| VKEKVVAL \| WVKEKVVAL \| AELEDDFKEGY \| APRGDKEEL \| LEDDFKEGY \| VQ ^dALWKQF \| VQALWKQF \| YYEEQHPEL
P12004	Proliferating cell nuclear antigen (PCNA)	261	3.6	10.6	KLMDLDVEQL \| SMSADVPLV \| ILKKVLEAL \| LMD ^oLDVEQL \| RLVQGSILKK \| VVKMPSGEF \| KLM ^oDLDVEQL \| TPLSSTVTL \| SM ^oSADVPLV
O00560	Syntenin‐1 (SDCBP)	298	6.2	8.8	LMDHTIPEV \| RPFERTITM \| RPFERTITM ^o \| SLMDHTIPEV \| KVIQAQTAF \| RLYPELSQY \| LM ^oDHTIPEV \| SLM ^oDHTIPEV \| RPFERTITM ^s \| SLMDHT ^hIPEV \| AHKVLKQAF \| KVIQAQ ^dTAF
P04844	Ribophorin‐2 (RPN‐2)	631	5.4	7.1	NRMLAQQAV \| NRYHVPVVV \| NRYHVPVVVV \| SIAPKTTRVTY \| TPHQTFVRL \| ALSALTARL \| ATVLQKTSF \| FIADSHQNF \| RLDELGGVYL \| RMLAQQAVK \| YAAQASQAL \| IYHAVAAL \| RYIANTVEL \| RVTYPAKAK \| SEDSSVTQIY \| SVASAAAVLSH \| VEVEGDNRY \| ATVLQ ^dKTSF \| NRYIANTV

Peptides presented by all six patients are underlined. Modified amino acids are depicted in bold, peptide modifications are abbreviated as follows: a, acetylation (42.01); o, oxidation (+15.99 Da); d, deamidation (+0.98 Da); s, sulphone (+31.99 Da); h, dehydration (−18.01).